Martin Schwonzen
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Oncology top 10%
- Neutropenia and Cancer Infections
- CAR-T cell therapy research
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 2
- Viral-associated cancers and disorders 2
-
- Galectins and Cancer Biology 3
- T-cell and Retrovirus Studies 2
- Co-authors
- Volker Diehl (12 shared papers)Peter Mallmann (2 shared papers)Christian M. Kurbacher (2 shared papers)Michael Pfreundschuh (4 shared papers)Christoph Pohl (4 shared papers)Arnold Ganser (1 shared paper)Regina Reutzel (1 shared paper)T. Lipp (1 shared paper)
- Journals
- Blood (3 papers)International Journal of Cancer (3 papers)Anti-Cancer Drugs (2 papers)Leukemia Research (2 papers)British Journal of Haematology (2 papers)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Martin Schwonzen
27 papers receiving 490 citations
Peers
Comparison fields: 5 of 59
- Hematology 125
- Oncology 223
- Genetics 83
- Pathology and Forensic Medicine 105
- Immunology 120
Countries citing papers authored by Martin Schwonzen
This map shows the geographic impact of Martin Schwonzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Schwonzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Schwonzen more than expected).
Fields of papers citing papers by Martin Schwonzen
This network shows the impact of papers produced by Martin Schwonzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Schwonzen. The network helps show where Martin Schwonzen may publish in the future.
Co-authors
The 25 scholars most cited alongside Martin Schwonzen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 90 | |
| 2 | 2000 | 58 | |
| 3 | 1993 | 39 | |
| 4 | 1995 | 34 | |
| 5 | 1995 | 33 | |
| 6 | 1993 | 29 | |
| 7 | 1989 | 29 | |
| 8 | 1993 | 28 | |
| 9 | 1993 | 28 | |
| 10 | 2004 | 27 | |
| 11 | 2006 | 20 | |
| 12 | 1992 | 17 | |
| 13 | 1992 | 13 | |
| 14 | Monoclonal antibody FW6 defines an epitope on alpha 3/4-monofucosylated polylactosaminoglycans expressed by fetal and colon carcinoma-associated mucins. | 1993 | 11 |
| 15 | 1992 | 10 | |
| 16 | 1996 | 8 | |
| 17 | Monoclonal antibody SP-21 defines a sialosyl-Tn antigen expressed on carcinomas and K562 erythroleukemia cells. | 1993 | 8 |
| 18 | 1995 | 7 | |
| 19 | 1998 | 6 | |
| 20 | 2002 | 4 |
About Martin Schwonzen
Martin Schwonzen is a scholar working on Oncology, Immunology, Molecular Biology, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 27 papers that have together received 512 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Glycosylation and Glycoproteins Research (5 papers), Acute Myeloid Leukemia Research (5 papers), Galectins and Cancer Biology (3 papers), Cancer Treatment and Pharmacology (2 papers), Viral-associated cancers and disorders (2 papers) and T-cell and Retrovirus Studies (2 papers). The work is most often cited by research in Hematology (125 citations), Oncology (223 citations), Genetics (83 citations), Pathology and Forensic Medicine (105 citations) and Immunology (120 citations). Martin Schwonzen has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Volker Diehl, Peter Mallmann, Christian M. Kurbacher, Michael Pfreundschuh, Christoph Pohl, Arnold Ganser, Regina Reutzel, T. Lipp, Oliver G. Ottmann and D. Hoelzer. Their work appears in journals such as Blood, International Journal of Cancer, Anti-Cancer Drugs, Leukemia Research and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.